Biomarkers with digital technology and digital biomarkers for medication management

Mizuki Morita

doi:10.2745/dds.37.17

Biomarkers with digital technology and digital biomarkers for medication management

Research output: Contribution to journal › Article › peer-review

Abstract

If the therapeutic agent can be introduced into the patient’s body at the optimal time and in the optimal dose, or if the optimal concentration can be maintained by doing so, it should be possible to provide a higher quality of care than is currently available. One strategy is to monitor the patient’s condition and the concentrations of therapeutic agents in the body, and then to estimate the timing and dosage of medication. This paper describes the research and development of digital technology-based biomarkers and digital biomarkers for several diseases and conditions（diabetes, Parkinson’s disease, asthma, COPD, pain, itch, hypertension）that are being implemented to optimize treatment.

Original language	English
Pages (from-to)	17-24
Number of pages	8
Journal	Drug Delivery System
Volume	37
Issue number	1
DOIs	https://doi.org/10.2745/dds.37.17
Publication status	Published - 2022

Keywords

biomarker
digital biomarker
drug therapy monitoring
medication optimization

ASJC Scopus subject areas

Pharmaceutical Science

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2745/dds.37.17

Cite this

@article{38f7c805fc074fc5a82b15c700ffd24f,

title = "Biomarkers with digital technology and digital biomarkers for medication management",

abstract = "If the therapeutic agent can be introduced into the patient{\textquoteright}s body at the optimal time and in the optimal dose, or if the optimal concentration can be maintained by doing so, it should be possible to provide a higher quality of care than is currently available. One strategy is to monitor the patient{\textquoteright}s condition and the concentrations of therapeutic agents in the body, and then to estimate the timing and dosage of medication. This paper describes the research and development of digital technology-based biomarkers and digital biomarkers for several diseases and conditions（diabetes, Parkinson{\textquoteright}s disease, asthma, COPD, pain, itch, hypertension）that are being implemented to optimize treatment.",

keywords = "biomarker, digital biomarker, drug therapy monitoring, medication optimization",

author = "Mizuki Morita",

note = "Publisher Copyright: {\textcopyright} 2022, Japan Society of Drug Delivery System.",

year = "2022",

doi = "10.2745/dds.37.17",

language = "English",

volume = "37",

pages = "17--24",

journal = "Drug Delivery System",

issn = "0913-5006",

publisher = "Japan Society of Drug Delivery System",

number = "1",

}

TY - JOUR

T1 - Biomarkers with digital technology and digital biomarkers for medication management

AU - Morita, Mizuki

PY - 2022

Y1 - 2022

N2 - If the therapeutic agent can be introduced into the patient’s body at the optimal time and in the optimal dose, or if the optimal concentration can be maintained by doing so, it should be possible to provide a higher quality of care than is currently available. One strategy is to monitor the patient’s condition and the concentrations of therapeutic agents in the body, and then to estimate the timing and dosage of medication. This paper describes the research and development of digital technology-based biomarkers and digital biomarkers for several diseases and conditions（diabetes, Parkinson’s disease, asthma, COPD, pain, itch, hypertension）that are being implemented to optimize treatment.

AB - If the therapeutic agent can be introduced into the patient’s body at the optimal time and in the optimal dose, or if the optimal concentration can be maintained by doing so, it should be possible to provide a higher quality of care than is currently available. One strategy is to monitor the patient’s condition and the concentrations of therapeutic agents in the body, and then to estimate the timing and dosage of medication. This paper describes the research and development of digital technology-based biomarkers and digital biomarkers for several diseases and conditions（diabetes, Parkinson’s disease, asthma, COPD, pain, itch, hypertension）that are being implemented to optimize treatment.

KW - biomarker

KW - digital biomarker

KW - drug therapy monitoring

KW - medication optimization

UR - http://www.scopus.com/inward/record.url?scp=85129736233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85129736233&partnerID=8YFLogxK

U2 - 10.2745/dds.37.17

DO - 10.2745/dds.37.17

M3 - Article

AN - SCOPUS:85129736233

SN - 0913-5006

VL - 37

SP - 17

EP - 24

JO - Drug Delivery System

JF - Drug Delivery System

IS - 1

ER -

Biomarkers with digital technology and digital biomarkers for medication management

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this